Canada’s approach to Chemicals Management under the CMP – Domestic Update CEC SMOC Public Session San Antonio April 1&2, 2009

The Chemicals Management Plan (CMP) – a new era in chemicals management in Canada

2600 medium priorities 500 high priorities 4300 Priorities from Categorizatio n

High Priority Substances

The Challenge: 200 substances “released” in batches of 12-15 every 3 months - Petroleum stream: 164 substances - No longer in commerce:145 high-hazard substances

Medium Priority Substances

Initiated stakeholder discussions to develop approach

Low Priority Substances

Rapid screening using worst-case exposure scenarios – resulted in declaring 754 “not toxic ” 1200 low priorities 2

The Challenge Process

Current Status:

9 out of 12 batches released; final assessments published for first 3 batches; and, draft screening assessments for batches 4 and 5. Challenge to Industry – Call for information Draft screening assessment and RM Scope CG 1 Note process ends if substance is found to be “not toxic” under CEPA Final screening assessment and RM Approach CG 1 Proposed Order to add to CEPA List of Toxic Substances CG 1 Final Order to add to CEPA List of Toxic Substances CG 2 Publication of proposed instruments CG 1 Publication of final instruments CG 2 4-6 months 18 month Cabinet-imposed Timelines for Challenge 24 months to develop Proposed RM instrument in CEPA 18 months for final RM instrument in CEPA

Legend 60-day public comment period

, regulatory requirement under CEPA 1999 Regulatory timelines specified under CEPA 1999 3

Beyond the Challenge - Examples

•

Perfluorooctane sulfonate (PFOS):

• Regulations, June 11, 2008, prohibit the manufacture, use, sale, offer for sale or import of PFOS, as well as products containing PFOS, with certain exemptions.

•

Polybrominated diphenyl ethers (PBDEs):

• July 9, 2008: Regulations to prohibit manufacture of all PBDEs, and restrict import, use and sale of penta- and octaBDE commercial mixtures. • March 28, 2009: State of Science Report on decaBDE and updated risk management strategy, including: regulation to control PBDEs in manufactured products; an approach to minimize decaBDE releases from manufacturing operations; monitoring exposure to PBDEs; and end of life management strategy for products containing PBDEs. •

Post-challenge substances – Medium Priorities

• Consultations are underway to establish a framework to prioritize, assess and manage the next round of substances (approx. 4000) by 2020 •

Enhanced research, monitoring and surveillance

4

Strategies

•Grouping substances by sector, function or use profile can streamline the process for all stakeholders by consolidating input during all phases and linking future issues with existing actions.

Examples of Potential Strategies

–

Sector Strategies:

• Petroleum Sector • Plastics • Paints and Coatings • Forest Products –

Product Strategies

• Flame Retardants • Electronic Equipment –

Substance Strategies

–

Geographic Strategies

• the Great Lakes Binational Toxic Strategy (GLBTS) 5

Onwards

• • • Stakeholders have played an important role in the success of the CMP. CMP Stakeholder Advisory Council: Challenge Advisory Panel: CEPA National Advisory Committee and the Committee on Health and Environment: • • • With your continued participation and input, we aim to: Continuing to be science-based in our decisions Use right-sized management under the appropriate legislation identify more effective and innovative risk management approaches (such as sectoral approaches) to streamline risk management for all stakeholders Your feedback and continued dialogue helps us improve the delivery and continued success of the programme

Chemical Substances Web Site: ww.chemicalsubstanceschimiques.gc.ca

6